We are live on
!
Find out more
HMC
Harvard Management Company Portfolio holdings
AUM
$1.82B
1-Year Est. Return
26.23%
This Fund
S&P 500
This Quarter
Est. Return
-4.52%
1 Year Est. Return
+26.23%
3 Year Est. Return
+156.3%
5 Year Est. Return
+133.98%
10 Year Est. Return
+221.37%
AUM
$1.07B
AUM Growth
-$641M
(-38%)
Cap. Flow
-$556M
Cap. Flow
% of AUM
-52.17%
Top 10 Holdings %
Top 10 Hldgs %
75.23%
Holding
55
New
15
Increased
–
Reduced
5
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
+$49.7M |
| 2 |
Grab
GRAB
|
+$15.3M |
| 3 |
CFLT
Confluent
CFLT
|
+$9.4M |
| 4 |
Micron Technology
MU
|
+$8.02M |
| 5 |
Lam Research
LRCX
|
+$7.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$267M |
| 2 |
Royalty Pharma
RPRX
|
+$143M |
| 3 |
Meta Platforms (Facebook)
META
|
+$113M |
| 4 |
Affirm
AFRM
|
+$76.7M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$36.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.23% |
| 2 | Communication Services | 28.34% |
| 3 | Consumer Discretionary | 16.85% |
| 4 | Technology | 9.73% |
| 5 | Financials | 2.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LNW
1
DELISTED
Light & Wonder
LNW
| $179M | 16.8% |
2,678,571
| – | – |
|
2
Alphabet (Google) Class A
GOOGL
$3.91T
| $177M | 16.59% |
1,220,320
-1,080
| -0.1% | -$156K |
|
|
3
Royalty Pharma
RPRX
$26.1B
| $138M | 12.96% |
3,464,990
-3,677,866
| -51% | -$143M |
|
|
4
Meta Platforms (Facebook)
META
$1.51T
| $125M | 11.75% |
372,125
-340,948
| -48% | -$113M |
|
5
AbCellera Biologics
ABCL
$1.62B
| $58.7M | 5.51% |
4,105,095
| – | – |
|
|
EQRX
6
DELISTED
EQRx, Inc. Common Stock
EQRX
| $35.9M | 3.37% |
+5,262,161
| New | +$49.7M |
|
7
10x Genomics
TXG
$5.87B
| $27.7M | 2.6% |
186,143
| – | – |
|
8
Recursion Pharmaceuticals
RXRX
$1.57B
| $25.9M | 2.43% |
1,509,254
| – | – |
|
|
9
Affirm
AFRM
$23.5B
| $17.5M | 1.64% |
173,560
-580,244
| -77% | -$76.7M |
|
10
Revolution Medicines
RVMD
$40.2B
| $16.9M | 1.58% |
670,382
| – | – |
|
11
Relay Therapeutics
RLAY
$4.02B
| $16.6M | 1.56% |
541,124
| – | – |
|
12
Praxis Precision Medicines
PRAX
$9.07B
| $15.3M | 1.44% |
51,901
| – | – |
|
|
13
Grab
GRAB
$13.5B
| $14.3M | 1.34% |
+2,000,000
| New | +$15.3M |
|
14
Tenaya Therapeutics
TNYA
$168M
| $12.8M | 1.2% |
673,270
| – | – |
|
15
Rocket Lab Corp
RKLB
$39.9B
| $12.3M | 1.15% |
1,000,000
| – | – |
|
|
MEKA
16
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
| $11.6M | 1.09% |
1,000,000
| – | – |
|
17
PureCycle Technologies
PCT
$1.17B
| $10.2M | 0.96% |
1,069,600
| – | – |
|
|
CFLT
18
DELISTED
Confluent
CFLT
| $9.94M | 0.93% |
+130,383
| New | +$9.4M |
|
|
19
Micron Technology
MU
$1.04T
| $9.56M | 0.9% |
+102,684
| New | +$8.02M |
|
20
Nurix Therapeutics
NRIX
$2.43B
| $9.11M | 0.86% |
314,762
| – | – |
|
|
21
Lam Research
LRCX
$382B
| $9M | 0.85% |
+125,210
| New | +$7.85M |
|
|
KNTE
22
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $8.82M | 0.83% |
498,001
| – | – |
|
23
Applied Materials
AMAT
$426B
| $7.96M | 0.75% |
+50,553
| New | +$7.32M |
|
24
Advanced Micro Devices
AMD
$851B
| $7.86M | 0.74% |
+54,610
| New | +$7.34M |
|
25
Intel
INTC
$466B
| $7.77M | 0.73% |
+150,806
| New | +$7.71M |
|
Similar funds
DWT
MCC
ST
DE
SI
WIC
GC
RHJA
Harvard Management Company's Q4 2021 Portfolio in Review
As of Q4 2021, Harvard Management Company held 55 positions worth $1.07B, down 38% from $1.71B the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Harvard Management Company withdrew a net $556M in Q4 2021, closing 9 positions and reducing 5 holdings. Its most notable exit was Apple, an estimated $267M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 34% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Harvard Management Company opened a new position in EQRx, Inc. Common Stock worth $35.9M.
- Harvard Management Company's largest Q4 2021 buy was EQRx, Inc. Common Stock: 5,262,161 shares worth $35.9M.
- Harvard Management Company's biggest Q4 2021 reduction was Royalty Pharma, cutting an estimated $143M.
- Harvard Management Company fully exited Apple in Q4 2021, selling an estimated $267M.
- Harvard Management Company's ten largest holdings make up 75% of its $1.07B portfolio in Q4 2021.
- Harvard Management Company opened 15 new positions and closed 9 in Q4 2021.
- Harvard Management Company's portfolio value fell 38% quarter-over-quarter to $1.07B.
Based on Harvard Management Company's 13F filing for Q4 2021, filed 11 Feb 2022.